Skip to main content

People in the News: Sep 1, 2010


PrimeraDx said this week that it has appointed Matthew McManus as president and CEO.

McManus, who will also join PrimeraDx's board of directors, was previously head of Cleveland Clinic Laboratories and COO of the Pathology and Laboratory Medicine Institute. Prior to this, he was a medical scientist for the Novartis Institutes for Biomedical Research Drug Discovery Incubator. He has also worked at McKinsey & Company and Proctor & Gamble. He holds an MD and PhD from the University of Pennsylvania School of Medicine and an MBA from Boston College.

HTG said this week that it has appointed John Wineman as vice president of new business development, western region; and Thomas Vasicek as vice president of clinical programs and product innovation.

Wineman will be responsible for commercial sales and new business growth for the western region of North America and Asia, HTG said. Prior to joining HTG, Wineman was director of business development for FEI's Life Science division. Prior to that, he serves as director of strategic marketing and director of corporate development for Roche Diagnostics' Ventana Medical Systems group.

Wineman has also worked for LifeSpan Biosciences, Becton-Dickinson, and Bio-Rad Laboratories. He holds an MBA from San Diego State University and a BS in biology from Oregon State University.

Vasicek will be responsible for leading HTG's clinical programs and establishing HTG's new assay innovation roadmap, HTG said. Prior to joining the company, Vasicek was senior director of medical innovation for Roche's Ventana Medical Systems group. Prior to that, he served as senior director of bioscience technology development at Medtronic.

Vasicek has also served as vice president of business development for Solexa/Lynx Therapeutics; CSO for LabSeek Scientific Collaboration; director of commercial technology for Corning's life sciences group; senior scientist at Millennium Pharmaceuticals; and a visiting scientist at the Whitehead Institute. He holds a PhD in genetics from Harvard University and completed his postdoc at Princeton University.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.